Last updated at 11 May 2025 10:53 AM
Director
DIN: 03245556
Lovi Padha is currently associated with 3 companies in various capacities such as Director and Designated Partner. They serve as a Director at GENNEXT DIAGNOSTICS & RESEARCH PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03245556.Lovi Padha has previously been associated with 2 companies in roles such as Director and Additional Director.Lovi Padha is currently involved in 2 different roles. Their most recent position is with CARE COVE MEDICLINIC LLP as a Designated Partner. The first company Lovi Padha was appointed to as a director was GENNEXT DIAGNOSTICS & RESEARCH PRIVATE LIMITED. Lovi Padha is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Lovi Padha is currently associated with 3 companies in various capacities such as Director and Designated Partner. They serve as a Director at GENNEXT DIAGNOSTICS & RESEARCH PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03245556.Lovi Padha has previously been associated with 2 companies in roles such as Director and Additional Director.Lovi Padha is currently involved in 2 different roles. Their most recent position is with CARE COVE MEDICLINIC LLP as a Designated Partner. The first company Lovi Padha was appointed to as a director was GENNEXT DIAGNOSTICS & RESEARCH PRIVATE LIMITED. Lovi Padha is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (2)
Past Companies (2)
3y 1m 1y 7m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| GENNEXT DIAGNOSTICS & RESEARCH PRIVATE LIMITED | Director | 27-Dec-2020 |